Over 1650 Total Lots Up For Auction at Two Locations - PA 07/14, NJ Cleansweep 07/16

Joseph J. Cappello

Are You Dense, Inc. and Are You Dense Advocacy, Inc. announce executive director of both organizations
February 19, 2019
Women's Health
Joseph J. Cappello
Woodbury, Conn., Feb. 18, 20019 — The boards of the two nonprofits founded by the late Nancy M. Cappello, PhD, has announced today Joseph J. Cappello as their new executive director. For over a decade, Mr. Cappello has worked tirelessly, side-by-side as co-founder of the organizations with his wife, Dr. Cappello, earning him a unique perspective of the critical issue on adjunct screening for women with dense breast tissue.

"Duty compels me to carry on my wife's mission," declares Mr. Cappello. "Women have the right to know their breast density status, to have their complete breast health information. This vital piece of information was denied to Nancy when she was originally diagnosed with late stage 3c breast cancer in 2004. As a result of her hard work, 36 states currently mandate physicians to tell their patients their breast density status.

"Now, we are focusing our energies on getting legislation passed in the remaining 14 states" adds Mr. Cappello.
stats
DOTmed text ad

We repair MRI Coils, RF amplifiers, Gradient Amplifiers and Injectors.

MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013

stats
Science for decades has demonstrated that dense breast tissue is associated with a higher-than-average risk of breast cancer and that dense breast tissue can mask cancers on mammograms, making them impossible to detect. Adjunct screening to mammography, such as ultrasound and MRI, significantly increase detection of early cancers in dense breasts.

Dr. Cappello launched the legislative action of her organizations after being diagnosed with advanced-stage breast cancer in 2004 despite decades of normal mammography results. None of Dr. Cappello's physicians told her that she had dense breast tissue, which had hidden the growing cancer in her breast, and none advised her to get adjunct screening. Her home state of Connecticut passed the first bill in 2009.

Dr. Cappello passed away this past November due to complications from Myelodysplastic syndrome (MDS), a rare form of bone marrow cancer, and in some instances, may be associated with previous radiation and chemotherapy cancer treatments.

"I am empowered and honored to further the Are You Dense? mission," continues Mr. Cappello. "That being to reduce missed, delayed and advanced stage breast cancer by increasing access to early detection for women with dense breasts leading to reduced harms from aggressive treatments and better survival outcomes."

You Must Be Logged In To Post A Comment

 

advertisement

Women's Health Homepage

FDA clears Siemens Healthineers contrast-enhanced mammo, biopsy features
Mammomat B.brilliant can now utilize ClearCEM image reconstruction technique
Deep learning method could sharpen breast MR while capturing faster contrast dynamics
Enhanced Locally low-rank Imaging for Tissue contrast Enhancement (ELITE) shows promise
Hologic wins patent case against Siemens Healthineers over mammo technology
The UPC ruling may prevent further sales of MammoMAT B.brilliant systems in certain European countries
HOPPR launches mammo vision-language model for imaging developers
Converts mammography images into narrative language and structured JSON outputs
Lunit touts growth in US adoption of breast imaging AI, FDA clearance for updated 3D tool
Now deployed at more than 330 screening sites across the Americas
GE HealthCare expands mammography collaboration with DeepHealth
Latest phase adds international distribution and introduces additional workflow tools
Mammotome receives FDA clearance for MR-guided breast biopsy system and marker
First vacuum-assisted system designed for use inside the MR suite
FDA clears updated configuration of QT Imaging’s Breast Acoustic CT scanner
Update takes aim at visualization of tissue near the chest wall
QT Imaging secures Category III CPT code for 3D breast ultrasound tomography
Code applies to radiation-free, compression-free breast imaging platform generating true 3D volumetric images
Portable ultrasound system may support earlier breast cancer detection
Can image up to 15 centimeters deep, captures entire breast from two or three positions